Testimonials
Lobular breast cancer grade 3 and Diabetes Mellitus | Woman, age 48
The patient was diagnosed with breast cancer in December 2012. She heard ofGanod.. Read More
Angina pectoris, Diabetes Mellitus, Hypertension and Struma thyroidae | Woman, age 78
Before she started usingGanoderma Lucidum Spore Oil Softgels, this patients suga.. Read More
Breast cancer | Woman, age 66
This patient was diagnosed with breast cancer in January of 2011. She was operat.. Read More
Colon cancer with metastasis on the liver | Man, age 73
In 2009 he left breast was removed, however on a follow up examination in Septem.. Read More
Ganoderma Plantation Ganoderma Farm
Ganoderma Town

Ganoderma lucidum polysaccharides on the immune functions of patients with advanced lung cancer

 Journal of Medicinal Food 2005 Summer; 8(2):159-68

Effects of water-soluble Ganoderma lucidum polysaccharides on the immune functions of patients with advanced lung cancer

Institute of Food, Nutrition and Human Health, Massey University, New Zealand

Preclinical studies have established that the polysaccharide fractions of Ganoderma lucidum have potential antitumor activity. Recent clinical studies have demonstrated that G. lucidum polysaccharides enhance host immune functions [e.g., enhanced natural killer (NK) cell activity] in patients with advanced solid tumors, although an objective response was not observed. This open-label study aimed to evaluate the effects of water-soluble G. lucidum polysaccharides (Ganopoly, Encore International Corp., Auckland, New Zealand) on immune functions in patients with advanced lung cancer. Thirty-six patients were enrolled and treated with 5.4 g/day Ganopoly for 12 weeks. In the 30 cancer patients who completed the trial, treatment with Ganopoly did not significantly alter the mean mitogenic reactivity to phytohemagglutinin, mean counts of CD3, CD4, CD8, and CD56, mean plasma concentrations of interleukin (IL)-2, IL-6, and interferon (IFN)-gamma, or NK activity in the patients, but the results were significantly variable. However, some cancer patients demonstrated markedly modulated immune functions. The changes in IL-1 were correlated with those for IL-6, IFN-gamma, CD3, CD8, and NK activity (P < .05), and IL-2 changes were correlated with those for IL-6, CD8, and NK activity. The results suggest that subgroups of cancer patients might be responsive to Ganopoly in combination with chemotherapy/radiotherapy. Further studies are needed to explore the efficacy and safety of Ganopoly used alone or in combination with chemotherapy/radiotherapy in lung cancer patients.

PMID: 16117607 [PubMed – indexed for MEDLINE]

 

 



Copyright © 2012 GANODERMATOWN.COM. All rights reserved.